Infectious Diseases

Papers
(The H4-Index of Infectious Diseases is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Influenza-associated invasive aspergillosis in patients admitted to the intensive care unit in Sweden: a prospective multicentre cohort study906
Molecular epidemiology and evolution of norovirus in Australia and New Zealand, 2018 to 202058
Low incidence of severe bacterial infections in hospitalised patients with COVID-19: A population-based registry study43
The possible role of serum bactericidal titres in long-term suppressive antibiotic treatment for infective endocarditis: report of three cases34
Operational feasibility and multi-centric evaluation of ‘TB Detect sputum microscopy kit’ for the direct detection of Mycobacterium tuberculosis 32
A nationwide evaluation of antibiotics consumption in Swedish intensive care units30
Long-term risk of HCC in a DAA-treated national hepatitis C cohort, and a proposed risk score27
Acyclovir treatment of varicella-zoster virus meningeal infections and acute kidney injury: a multicentre case series study26
Tuberculosis in migrants: epidemiology, resistance and outcome in Milan, Italy26
Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017–202125
Association of HLA-Ib (HLA-G, HLA-E and HLA-F) with spontaneous HBV clearance25
Environmental contamination of Opisthorchis viverrini eggs and its impact on transmission control in rural northeast Thailand24
Influence of viral load on severity and mortality in COVID-1923
Infant botulism: an underestimated threat22
Evaluation of the 2023 Duke-ISCVID criteria for infective endocarditis in patients referred to the Lund infective endocarditis team21
Infective endocarditis in HIV-infected patients. Analysis of a national cohort20
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone20
SARS-CoV-2 late shedding may be infectious between immunocompromised hosts17
Proper duration of antibiotics after video-assisted thoracoscopic surgery for the treatment of thoracic empyema17
Time to positivity of blood cultures in bloodstream infections with Streptococcus dysgalactiae and association with outcome17
Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders17
60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden17
0.44824194908142